Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases

British Journal of Cancer

Volumn 112, Issue 3, 2015, Pages 556-561

  Lalmahomed, Z S ^a   Mostert, B ^b   Onstenk, W ^b   Kraan, J ^b   Ayez, N ^b   Gratama, J W ^b   Grunhagen D ^b   Verhoef, C ^b   Sleijfer, S ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

CellSearch system; circulating tumour cells; colorectal liver metastases; disease recurrence; hepatic resection; prognostic marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; DENSITY GRADIENT; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; CELL SEPARATION; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RECURRENT DISEASE; SECONDARY; TUMOR EMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL SEPARATION; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE;

EID: 84922122055     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.651     Document Type: Article

References (34)

1. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S Paule B, Kunstlinger F, Ghemard O, Levi F, Bismuth H (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657.
2. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG Uhr JW, Terstappen LW (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904.
3. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A Bismuth H (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231: 480-486.
4. Chau TC, Saxena A, Liauw W, Chi F, Morris DL (2012) Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases-a systematic review. Eur J Cancer 48: 1575-65.
5. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW Meropol NJ (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26: 3213-3221.
6. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J Morse MA, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW Meropol NJ (2009) Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20: 1223-1229.
7. Coumans FA, Ligthart ST, Uhr JW, Terstappen LW (2012) Challenges in the enumeration and phenotyping of CTC. Clin Cancer Res 18: 5711-5718.
8. de Meijer VE, Verhoef C, Kuiper JW, Alwayn IP, Kazemier G, Ijzermans JN (2006) Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 10: 960-973.
9. Dols LF, Verhoef C, Eskens FA, Schouten O, Nonner J, Hop WC Mendez Romero A, de Man RA, van der Linden E, Dwarkasing RS Ijzermans JN (2009) [Improvement of 5 year survival rate after liver resection for colorectal metastases between 1984-2006] Verbetering in 5-jaarsoverleving na leverresectie voor colorectale metastasen tussen 1984-2006. Ned Tijdschr Geneeskd 153: 490-495.
10. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318.
11. Gazzaniga P, Raimondi C, Gradilone A, Biondi ZOCCAI G, Nicolazzo C Gandini O, Longo F, Tomao S, Lo Russo G, Seminara P, Vincenzi B Chimenti I, Cristofanilli M, Frati L, Cortesi E (2013) Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? J Cancer Res Clin Oncol 139: 1411-1416.
12. Gross S, Bui T, Rao C, Connelly M, Terstappen WMM (2005) Modified Ficoll preprocessing procedure for 30mL of whole blood prior to cellsearch circulating tumor cell test. 5th International Symposium on Minimal Residual Cancer; 10-13 September; San Francisco, CA, USA.
13. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG Hawkins IF, Vauthey JN (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237: 686-691.
14. Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, Kumagai K Irino T, Yoshikawa T, Matsuda S, Kitajima M, Kitagawa Y (2008) Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 15: 3092-3100.
15. House MG, Ito H, Gonen M, Fong Y, Allen PJ, Dematteo RP, Brennan MF Blumgart LH, Jarnagin WR, Dangelica MI (2010) Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg 210: 744-752.
16. Jiao LR, Apostolopoulos C, Jacob J, Szydlo R, Johnson N, Tsim N, Habib NA Coombes RC, Stebbing J (2009) Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol 27: 6160-6165.
17. Kaifi JT, Kunkel M, Zhu J, Dicker DT, Gusani NJ, Yang Z, Sarwani NE, Li G Kimchi ET, Staveley-OCarroll KF, El-Deiry WS (2013) Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients. Cancer Biol Ther 14: 1174-1181.
18. Koch M, Kienle P, Hinz U, Antolovic D, Schmidt J, Herfarth C von Knebel Doeberitz M, Weitz J (2005) Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases. Ann Surg 241: 199-205.
19. Lalmahomed ZS, Kraan J, Gratama JW, Mostert B, Sleijfer S, Verhoef C (2010) Circulating tumor cells and sample size: the more, the better. J Clin Oncol 28: e288-e289author reply e290.
20. Matsusaka S, Suenaga M, Mishima Y, Kuniyoshi R, Takagi K, Terui Y Mizunuma N, Hatake K (2011) Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer. Cancer Sci 102: 1188-1192.
21. Mendez Romero A, Wunderink W, Hussain SM, de Pooter JA, Heijmen BJ Nowak PC, Nuyttens JJ, Brandwijk RP, Verhoef C, Ijzermans JN, Levendag PC (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol 45: 831-837.
22. Mostert B, Jiang Y, Sieuwerts AM, Wang H, Bolt-de Vries J, Biermann K Kraan J, Lalmahomed Z, van Galen A, de Weerd V, van der Spoel P Ramirez-Moreno R, Verhoef C, Ijzermans JN, Wang Y, Gratama JW Foekens JA, Sleijfer S, Martens JW (2013) KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int J Cancer 133: 130-141.
23. Mostert B, Sleijfer S, Foekens JA, Gratama JW (2009) Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 35: 463-474.
24. Neki K, Kawahara H, Watanabe K, Toyama Y, Akiba T, Yanaga K (2013) Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer. Anticancer Res 33: 1769-1772.
25. Rahbari NN, Aigner M, Thorlund K, Mollberg N, Motschall E, Jensen K Diener MK, Buchler MW, Koch M, Weitz J (2010) Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138: 1714-1726.
26. Rees M, Tekkis PP, Welsh FK, ORourke T, John TG (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135.
27. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905-914.
28. Seeberg LT, Waage A, Brunborg C, Hugenschmidt H, Renolen A, Stav I Bjornbeth BA, Brudvik KW, Borgen EF, Naume B, Wiedswang G (2014) Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival. Ann Surg.
29. Stebbing J, Harding V, Urch CE, Kaier T, Schofield G, Flook M, Alifrangis C Young AM, Shaw JA, Coombes RC, Krell J (2014) The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancy. Future Oncol; e-pub ahead of print 30 May 2014.
30. Strijbos MH, Gratama JW, Schmitz PI, Rao C, Onstenk W, Doyle GV Miller MC, de Wit R, Terstappen LW, Sleijfer S (2010) Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel. Eur J Cancer 46: 2027-2035.
31. Tol J, Koopman M, Miller MC, Tibbe A, Cats A, Creemers GJ, Vos AH Nagtegaal ID, Terstappen LW, Punt CJ (2010) Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol 21: 1006-1012.
32. Topal B, Aerts JL, Roskams T, Fieuws S, van Pelt J, Vandekerckhove P Penninckx F (2005) Cancer cell dissemination during curative surgery for colorectal liver metastases. Eur J Surg Oncol 31: 506-511.
33. Vlems FA, Diepstra JH, Punt CJ, Ligtenberg MJ, Cornelissen IM, van Krieken JH Wobbes T, van Muijen GN, Ruers TJ (2003) Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg 90: 989-995.
34. Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd 3RD GD, Dorfman GS Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, Michelson R, Poston GJ Schrag D, Seidenfeld J, Benson 3RD AB (2010) American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28: 493-508.